HF 3333 - Controlled Substance Schedules Modification

• Adds acetyl fentanyl to Schedule I opiates as a synthetic fentanyl analog intended for human consumption.

• Adds 2-MeO-2-deschloroketamine (methoxyketamine) to Schedule I central nervous system depressants.

• Adds 71 new hallucinogenic substances to Schedule I, including various tryptamine analogs, phenethylamines (2C series), and other synthetic compounds like methoxetamine and MDAI.

• Adds eluxadoline to Schedule IV narcotic drugs in limited quantities.

• Adds lorcaserin to Schedule IV stimulants.